Press release
Deadline coming up in Lawsuit filed for Investors in shares of Amarin Corporation plc (NASDAQ: AMRN)
A Deadline is coming up on December 23, 2021 in the lawsuit for certain investors in Amarin Corporation plc.
Investors who purchased shares of Amarin Corporation plc (NASDAQ: AMRN) have certain options and there are strict and short deadlines running. Deadline: December 23, 2021. (NASDAQ: AMRN)stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the District Court for the District of New Jersey the plaintiff alleges on behalf of purchasers of Amarin Corporation plc (NASDAQ: AMRN) common shares between December 5, 2018, and June 21, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between December 5, 2018, and June 21, 2021, the Defendants made false and misleading statements and/or failed to disclose that there was an increasingly high risk that certain of Amarin’s patents would be invalidated, that once certain of Amarin’s patents were invalidated by the United States District Court for the District of Nevada, there was little to no chance of reversing that ruling, that the Company’s litigation was preventing it from effectuating a successful takeover, that Defendants were downplaying the true threat the ongoing Abbreviated New Drug Application ("ANDA") litigation posed to the Company’s business and future prospects, and that as a result, the Company’s public statements were materially false and misleading at all relevant times.
Those who purchased shares of Amarin Corporation plc (NASDAQ: AMRN) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline coming up in Lawsuit filed for Investors in shares of Amarin Corporation plc (NASDAQ: AMRN) here
News-ID: 2492534 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Amarin
Omega 3 Prescription Drugs Market Estimated to Reach USD 2.63 Billion by 2030 | …
The latest report by Congruence Market Insights, titled 'Global Omega 3 Prescription Drugs Market - Size, Trends, Share, Growth, Dynamics, Competition, and Opportunity Forecast, 2023 - 2030,' presents a comprehensive analysis of the global omega 3 prescription drugs market. This report meticulously examines both macro and micro trends, providing insights into factors influencing the market dynamics. It delves into qualitative and quantitative aspects, presenting a precise depiction of market size,…
Omega 3 Prescription Drug Market Outlook Highlights Major Opportunities by 2030 …
Omega 3 Prescription Drug Market Report research report is a wide-ranging analysis of and in the global market and in-detail information with segmentation has been added in this intelligence report. In this report, a comprehensive analysis of the current global Global Omega 3 Prescription Drug Market market in terms of demand and supply environment is provided, as well as price trends currently and in the next few years.
Global leading players…
Amarin Corporation plc (NASDAQ: AMRN) Investor Notice: Investigation of potentia …
An investigation on behalf of investors in shares of Amarin Corporation plc (NASDAQ: AMRN) concerning potential breaches of fiduciary duties by certain directors and officers of Amarin Corporation plc was announced.
Investors who are current long term investors in Amarin Corporation plc (NASDAQ: AMRN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in…
Lawsuit filed for Investors in shares of Amarin Corporation plc (NASDAQ: AMRN)
An investor, who purchased shares of Amarin Corporation plc (NASDAQ: AMRN), filed a lawsuit in the over alleged violations of Federal Securities Laws by Amarin Corporation plc.
Investors who purchased shares of Amarin Corporation plc (NASDAQ: AMRN) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2021. NASDAQ: AMRN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Ireland based…
Neurodegenerative Diseases Market by 2021-2025 | Pfizer, Bayer, AstraZeneca, Nov …
The Reports Web Analysts Forecasts the latest report on “Global Neurodegenerative Diseases Market Impact and Analysis by 2025”, according to report; The Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth.
Get Sample PDF Report Here:
https://www.reportsweb.com/inquiry&RW00014399065/sample?utm_source=opr&utm_medium=10300
Market Scenario:
It studies different models that address the challenges faced by several industries as well as stakeholders. This Neurodegenerative Diseases market is…
Dyslipidemia Market Trends and Updates 2020-2026 || Leading Players - Sanofi, Al …
Global dyslipidemia market is expected to rise gradually to an estimated value of USD 27.52 billion by 2026, registering a CAGR of 10.50% in the forecast period of 2019-2026 with the annual sales of USD 12.38 billion in the year of 2018. This rise in market value can be attributed to the increase in prevalence and awareness along with concerns regarding the health of patients.
Get Exclusive Sample Copy of This…
